NDC 83027-0150 – Viri Sode

Human Herpesvirus 5 16 [hp_X]/mL; Human Herpesvirus 1 16 [hp_X]/mL; Human Herpesvirus 2 16 [hp_X]/mL; Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1)… · Spray · Oral

Human Otc Drug

Product NDC83027-0150

Product details

Brand name
Viri Sode
Generic name
Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
Labeler
Nutritional Specialties, Inc.
Dosage form
Spray
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
June 3, 2025
Marketing end
May 7, 2030

Active ingredients

Uses, dosage, side effects and warnings for Viri Sode →

Package NDC codes (1)

Package NDCDescriptionSince
83027-0150-160 mL in 1 BOTTLE, SPRAY (83027-0150-1)Jun 3, 2025

Other Viri Sode products